Evidence map›Paper›PMID 20739354›Full record

ArticleMolecular & cellular proteomics : MCP2010

In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.

Sangwon Cha, Marcin B Imielinski, Tomas Rejtar, Elizabeth A Richardson, Dipak Thakur, Dennis C Sgroi, Barry L Karger

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Protein expression profile of rat type two alveolar epithelial cells during hyperoxic stress and recovery.American journal of physiology. Lung cellular and molecular physiology · 2013
    Article
  16. Article
  17. Article
  18. Laser capture microdissection for protein and NanoString RNA analysis.Methods in molecular biology (Clifton, N.J.) · 2013
    Article
  19. Differential expression analysis for pathways.PLoS computational biology · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Sangwon ChaBarnett Institute, Northeastern University, MA 02115, USA.
Marcin B Imielinski
Tomas Rejtar
Elizabeth A Richardson
Dipak Thakur
Dennis C Sgroi
Barry L Karger
Northeastern University · USHarvard University · USCenter for Cancer Research · USMassachusetts General Hospital · US

Funding

STUDIES IN HIGH PERFORMANCE LIQUID CHROMATOGRAPHYR01GM015847 · NIGMS · NORTHEASTERN UNIVERSITY · PI KARGER, BARRY L. · 1985 to 2013
$5.7M
A NOVEL BREAST CANCER BIOMARKERR01CA112021 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SGROI, DENNIS C · 2005 to 2013
$2.6M
MECHANISTIC STUDIES OF THE HYDROLYSIS OF NUCLEOSIDESF32GM015847 · NIGMS · UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS · PI MRACHKO, GREGORY T · 1993 to 1994
–
HPLC AND HPCE OF PROTEINSR37GM015847 · NIGMS · NORTHEASTERN UNIVERSITY · PI KARGER, BARRY L. · 1990 to 1999
–
NCI NIH HHS R01 CA112021NCI NIH HHS R01CA112021NIGMS NIH HHS F32 GM015847NIGMS NIH HHS GM15847NIGMS NIH HHS R01 GM015847NIGMS NIH HHS R37 GM015847
6 · The paper itself

Abstract

Identification of molecular signatures that allow detection of the transition from normal breast epithelial cells to malignant invasive cells is a critical component in the development of diagnostic, therapeutic, and preventative strategies for human breast cancer. Substantial efforts have been devoted to deciphering breast cancer etiology at the genome level, but only a limited number of studies have appeared at the proteome level. In this work, we compared individual in situ proteome profiles of nonpatient matched nine noncancerous, normal breast epithelial (NBE) samples with nine estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples by combining laser capture microdissection (LCM) and quantitative shotgun proteomics. A total of 12,970 unique peptides were identified from the 18 samples, and 1623 proteins were selected for quantitative analysis using spectral index (SpI) as a measure of protein abundance. A total of 298 proteins were differentially expressed between NBE and MBE at 95% confidence level, and this differential expression correlated well with immunohistochemistry (IHC) results reported in the Human Protein Atlas (HPA) database. To assess pathway level patterns in the observed expression changes, we developed protein set enrichment analysis (PSEA), a modification of a well-known approach in gene expression analysis, Gene Set Enrichment Analysis (GSEA). Unlike single gene-based functional term enrichment analyses that only examines pathway overrepresentation of proteins above a given significance threshold, PSEA applies a weighted running sum statistic to the entire expression data to discover significantly enriched protein groups. Application of PSEA to the expression data in this study revealed not only well-known ER-dependent and cellular morphology-dependent protein abundance changes, but also significant alterations of downstream targets for multiple transcription factors (TFs), suggesting a role for specific gene regulatory pathways in breast tumorigenesis. A parallel GOMiner analysis revealed both confirmatory and complementary data to PSEA. The combination of the two annotation approaches yielded extensive biological feature mapping for in depth analysis of the quantitative proteomic data.

Indexed as

LasersAdolescentAdultAgedBiomarkers, TumorBreast NeoplasmsEpithelial CellsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMicrodissectionMiddle AgedOligonucleotide Array Sequence AnalysisProteomeProteomicsBiomarkers, TumorProteome

Identifiers

PMID20739354
PMCPMC2984225
OpenAlexW1989095484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.